
Maintain core exposure to leading-edge chipmaker Taiwan Semiconductor Manufacturing Company (TSM), which commands near-monopolistic control over critical AI hardware fabrication.
Invest in natural gas providers, electrical grid suppliers, and small modular reactor (SMR) developers to capitalize on AI data center power shortages expected to persist through 2030 to 2032.
Focus enterprise software allocations on vertical enterprise AI platforms serving text-heavy industries like legal and finance, which present the clearest path to near-term corporate revenue.
Gain life sciences exposure through AI in biotechnology platform providers that sell high-margin discovery software directly to large pharmaceutical firms rather than taking on binary clinical trial risks.
Target specialized sensor and actuator suppliers within the embodied AI and robotics supply chain as physical automation accelerates toward commercialization faster than market consensus.

By @iltb_podcast
Conversations with the best investors and business leaders in the world. We explore their ideas, methods, and stories to help you ...